Monarch Partners Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-102,254
Closed -$6.01M 157
2022
Q2
$6.01M Buy
+102,254
New +$5.64M 1.68% 1
2020
Q2
Sell
-109,828
Closed -$4.03M 201
2020
Q1
$4.03M Buy
+109,828
New +$4.27M 1.41% 27
2016
Q4
Sell
-57,192
Closed -$2.76M 193
2016
Q3
$2.76M Buy
57,192
+26,809
+88% +$1.36M 0.26% 106
2016
Q2
$1.68M Sell
30,383
-450
-1% -$24.8K 0.17% 114
2016
Q1
$1.65M Sell
30,833
-96,580
-76% -$4.76M 0.17% 114
2015
Q4
$6.56M Buy
127,413
+68,063
+115% +$3.38M 0.68% 65
2015
Q3
$2.68M Sell
59,350
-5,400
-8% -$255K 0.33% 85
2015
Q2
$2.99M Buy
+64,750
New +$2.83M 0.41% 87

Other funds holding PBH

Monarch Partners Asset Management's PBH Position: Q3 2022 in Review

Monarch Partners Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2022, closing a stake of 102,254 shares — an estimated $6.01M sold.

Monarch Partners Asset Management first reported a position in PBH in Q2 2015 and held it in 8 quarters. The position peaked at $6.56M in Q4 2015. 279 funds tracked by Wall St. Rank hold PBH as of Q3 2022.

  • Monarch Partners Asset Management reported no remaining Prestige Consumer Healthcare position as of Q3 2022 after selling out during the quarter.
  • Monarch Partners Asset Management sold 102,254 Prestige Consumer Healthcare shares in Q3 2022, an estimated $6.01M.
  • Monarch Partners Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2015 and held it in 8 quarters.
  • Monarch Partners Asset Management's Prestige Consumer Healthcare position peaked at $6.56M in Q4 2015.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2022.

Based on Monarch Partners Asset Management's 13F filing for Q3 2022, filed 31 Oct 2022.